A Conversation with Dr. Stephan Urban, Who Developed the First Drug for hepatitis D
Update: 2021-10-22
Description
This is a special edition episode - Ed Tate, Director of Communications at the Hepatitis B Foundation was able to sit down with Dr. Stephan Urban the developer of the hepatitis D drug, Hepcludex. The drug, which blocks the entry of the hepatitis B and hepatitis D virus into the liver cell, was approved by the European Commission on 31 July 2020. Listen for more of their conversation.
Consider donating here to support programs like B Heppy!
Questions? Send them to: info@hepb.org
Our website: www.hepb.org
Support B Heppy!
Social Media: Instagram - Twitter - Facebook
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
